期刊文献+

miRNA与胆道闭锁肝纤维化 被引量:1

Micro RNA and hepatic fibrosis of biliary atresia
在线阅读 下载PDF
导出
摘要 胆道闭锁(BA)是婴儿期引起梗阻性黄疸的主要病因之一,以肝内外胆管进行性炎症和纤维性梗阻为主要特征,导致胆汁淤积和肝纤维化及肝硬化。肝纤维化中最重要的是肝星状细胞(HSC)的活化,这一过程受到多种机制的调节,其中mi RNA家族成员可通过调控靶基因的表达,进而作用于多种信号通路促进HSC的活化,在细胞外基质(ECM)的合成和降解中发挥调节作用。大量文献表明PI3K/Akt信号通路与肝纤维化的发生、发展密切相关,参与了活化HSC增殖、凋亡的调控,mi RNA通过各种靶基因激活PI3K/Akt信号通路,进而激活HSC,促进肝纤维化的发展。本文就胆道闭锁肝纤维化相关的mi RNA综述如下。 Biliary atresia (BA), an inflammatory sclerosing cholangiopathy, is the leading cause of cholestasis in infants. Pathologic features of BA include progressive inflammation and intrahepatic and extrahepatic bile duct fibrosis. BA is characterized by rapid liver fibrosis. The activation of hepatic stellate cell (HSC) is most important in liver fibrosis. Many mechanisms are involved in this process, miRNA can promote the activation of HSC through a variety of signaling pathways by regulating the expression of target gene, then playing a regulatory role in the synthesis and degradation of extracellular matrix (ECM). A lot of literatures show that PI3K/Akt is closely related to the occurrence and development of hepatic fibrosis. PI3K/ Akt signaling pathway is involved in the activation of HSC proliferation and apoptosis. MiRNA activates PI3K/Akt signaling pathway through various target genes, and then activates HSC to promote the development of liver fibrosis. In this paper, the miRNA related to biliary atresia of liver fibrosis is summarized.
出处 《天津医药》 CAS 2015年第11期1334-1338,共5页 Tianjin Medical Journal
基金 天津市卫生行业重点攻关项目(14KG129)
关键词 微RNAS 胆道闭锁 肝硬化 星形细胞 综述 microRNAs biliary atresia liver cirrhosis astrocytes review
作者简介 卫园园(1992-),女,硕士在读,主要从事胆道闭锁方面研究 通讯作者及审校者zhanjianghuatj@163.com
  • 相关文献

参考文献4

二级参考文献36

  • 1van Rooij E. The art of microRNA research[ J]. Circ Res,2011,108 (2) :219 -234.
  • 2Pekarsky Y, Croce CM. Is miR -29 an oncogene or tumor suppressor in CLL[ J]. Oncotarget,2010,1 (3) :224 -227.
  • 3Mott JL, Kurita S, Cazauave SC,et al. Transcriptional suppression of mir - 29b - 1/mir - 29a promoter by c - Myc, hedgehog, and NF - kappaB[ J]. J Cell Bioehem,2010, 110(5) :1155 -1164.
  • 4Garzon R, Heaphy CE, Havelange V ,et al. MicmRNA 29b functions in acute myeloid leukemia [ J ]. Blood, 2009,114 (26) : 5331 - 5341.
  • 5Xiong Y, Fang JH, Yun JP, et al. Effects of microRNA - 29 on apopto- sis, tumorigenicity, and prognosis of hepatocellular carcinoma [ J ]. Hepatology ,2010, 51 (3) : 836 - 845.
  • 6Wirkowska A, Paczek L. Liver fibrosis and cirrhosis - selected cyto- kines, growth factors and proteins[J]. Part II Przegl Lek,20l1,68 (4) :228 -230.
  • 7Yu FJ, Dong PH, Fan XF ,et al. Down - regulation of angiotensin Ⅱ by shRNA reduces collagen synthesis in hepatic stellate cells [ J ]. Int J Mol Med,2010,25(5) : 801 -806.
  • 8Dong P, Yu F, Fan X, et al. Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells [ J ]. Mol Cell Biochem, 2010,344(1 -2) :195 -202.
  • 9Park SY, Lee JH, Ha M, et al. miR- 29 miRNAs activate p53 by targeting p85 alpha and CDC42 [ J]. Nat Struct Mol Biol, 2009, 16 (1) :23 -29.
  • 10Anastasiadou E, Boccellato F, Vincenti S, et al. Epstein - Barr virus encoded LMP1 downregulates TCL1 oncogene through miR - 29b [J]. Oncogene,2010,29(9) : 1316 - 1328.

共引文献18

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部